Page last updated: 2024-09-03

y 27632 and thromboplastin

y 27632 has been researched along with thromboplastin in 1 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(thromboplastin)
Trials
(thromboplastin)
Recent Studies (post-2010) (thromboplastin)
1,924389110,5402812,126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishimaru, Y; Narahara, S; Sakamoto, A; Sugiuchi, H; Yamaguchi, R; Yamaguchi, Y; Yamamoto, T1

Other Studies

1 other study(ies) available for y 27632 and thromboplastin

ArticleYear
Substance P enhances tissue factor release from granulocyte-macrophage colony-stimulating factor-dependent macrophages via the p22phox/β-arrestin 2/Rho A signaling pathway.
    Blood cells, molecules & diseases, 2016, Volume: 57

    Topics: Acetophenones; Adipocytes; Amides; Aprepitant; Arrestins; Benzopyrans; beta-Arrestin 2; beta-Arrestins; Dynamins; Free Radical Scavengers; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Activation; Macrophages; Morpholines; NADPH Oxidases; Neurokinin-1 Receptor Antagonists; Phosphorylcholine; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Pyrrolidines; rho-Associated Kinases; RNA, Small Interfering; Signal Transduction; Substance P; Thiocarbamates; Thromboplastin

2016